These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 25864682

  • 1. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
    Blatt AJ, Kennedy R, Luff RD, Austin RM, Rabin DS.
    Cancer Cytopathol; 2015 May; 123(5):282-8. PubMed ID: 25864682
    [Abstract] [Full Text] [Related]

  • 2. Age-specific 3-year cumulative risk of cervical cancer and high-grade dysplasia on biopsy in 9434 women who underwent HPV cytology cotesting.
    Ge Y, Christensen PA, Luna E, Armylagos D, Xu J, Hsu JW, Zhou H, Schwartz MR, Mody DR.
    Cancer Cytopathol; 2019 Dec; 127(12):757-764. PubMed ID: 31589379
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X, Griffith CC, Zhou X, Wang Z, Yan Y, Li Z, Zhao C.
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [Abstract] [Full Text] [Related]

  • 5. The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management.
    Gage JC, Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Behrens C, Sharma A, Zhao FH, Cuzick J, Yang ZH, Kinney WK.
    Cancer Cytopathol; 2014 Nov; 122(11):842-50. PubMed ID: 25045058
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen.
    Silver MI, Schiffman M, Fetterman B, Poitras NE, Gage JC, Wentzensen N, Lorey T, Kinney WK, Castle PE.
    Cancer; 2016 Dec 01; 122(23):3682-3686. PubMed ID: 27657992
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years.
    Stoler MH, Austin RM, Zhao C.
    J Clin Microbiol; 2015 Sep 01; 53(9):2798-804. PubMed ID: 25948606
    [Abstract] [Full Text] [Related]

  • 10. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.
    Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, Demuth F, Schiffman M, Wacholder S, Castle PE.
    Lancet Oncol; 2011 Jul 01; 12(7):663-72. PubMed ID: 21684207
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cervical cancer rates after the transition from annual Pap to 3-year HPV and Pap.
    Dinkelspiel H, Fetterman B, Poitras N, Kinney W, Cox JT, Lorey T, Castle PE.
    J Low Genit Tract Dis; 2014 Jan 01; 18(1):57-60. PubMed ID: 24022057
    [Abstract] [Full Text] [Related]

  • 17. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
    Li Z, Austin RM, Guo M, Zhao C.
    Arch Pathol Lab Med; 2012 Dec 01; 136(12):1533-40. PubMed ID: 22900617
    [Abstract] [Full Text] [Related]

  • 18. Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years.
    Silver MI, Rositch AF, Phelan-Emrick DF, Gravitt PE.
    Cancer Causes Control; 2018 Jan 01; 29(1):43-50. PubMed ID: 29124542
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.